Imiquimod - Warnings and Precautions
The following warnings and precautions are taken directly from the US FDA-approved drug label for Imiquimod. This is the same information dispensing pharmacists read.
5 WARNINGS AND PRECAUTIONS • Local Skin Reactions: Intense local inflammatory reactions can occur (e.g., skin weeping, erosion) Dosage interruption may be required.
Severe vulvar swelling may occur and lead to urinary retention; interrupt dosing or discontinue for severe vulvar swelling. • Local Hypopigmentation Reactions: Localized complete depigmentation has occurred and persisted.
Discontinue if hypopigmentation develops. • Systemic Reactions: Flu-like systemic signs and symptoms have occurred.
Consider dosage interruption for systemic reactions. • Ultraviolet Light Exposure Risks: Avoid or minimize exposure to sunlight and sunlamps.
Wear sunscreen and protective clothing.
5.1 Local Skin Reactions Local skin reactions including skin weeping or erosion have been reported with Imiquimod Cream and can occur after a few applications [see Adverse Reactions ] .
Concomitant use of Imiquimod Cream and any other imiquimod products, in the same treatment area, may increase the risk for and severity of local skin reactions.
Imiquimod Cream has the potential to exacerbate inflammatory conditions of the skin, including chronic graft versus host disease.
Severe local inflammatory reactions of the female external genitalia can lead to severe vulvar swelling and urinary retention.
Avoid sexual (genital, anal, oral) contact while Imiquimod Cream is on the skin.
To reduce the risk of local skin reactions and manage local skin reactions that occur with Imiquimod Cream treatment: • Avoid concomitant use of Imiquimod Cream with any other imiquimod product in the same treatment area. • Avoid application of Imiquimod Cream to skin that is not intact (i.e., any area with an abrasion, cut, burn, rash, infection, or other condition that has altered skin integrity). • An interruption of dosing may be required for local skin reactions [see Dosage and Administration ( 2.2 , 2.3 , 2.4 )] .
Interrupt dosing or discontinue Imiquimod Cream for severe vulvar swelling [see Dosage and Administration ] . • If severe local skin reactions occur, instruct patients to remove Imiquimod Cream by washing the treatment area with mild soap and water.
5.2 Local Hypopigmentation Reactions Cases of hypopigmentation, including complete depigmentation, were reported during postmarketing use of Imiquimod Cream.
In some cases, hypopigmentation and complete depigmentation did not improve or resolve with treatment and persisted for up to 60 months at the time of reporting.
Discontinue Imiquimod Cream if hypopigmentation develops.
5.3 Systemic Reactions Flu-like signs and symptoms have been reported with use of Imiquimod Cream and may accompany, or even precede, local inflammatory reactions [see Adverse Reactions ] .
Signs and symptoms may include malaise, fever, nausea, myalgias, and rigors.
Concomitant use of Imiquimod Cream and any other imiquimod products may increase the risk for and severity of systemic reactions.
Consider an interruption of dosing if systemic reactions occur.
5.4 Ultraviolet Light Exposure Risks Imiquimod Cream may cause heightened sunburn susceptibility.
Avoid or minimize exposure to sunlight (including sunlamps) during use of Imiquimod Cream.
Instruct patients to use sunscreen and wear protective clothing (e.g., a hat).
Advise patients not to use Imiquimod Cream until fully recovered from a sunburn.
Applies to YOU?
Some warnings apply only to specific age groups, health conditions, or other medicines. Ask GoDavaii AI to filter which of these 23+ warnings apply to your profile.
Ask Health AI \u2192